# OnCo record paper-firm-act-edp-mitotane-adrenocortical-carcinoma-nejm-2012 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-firm-act-edp-mitotane-adrenocortical-carcinoma-nejm-2012/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-firm-act-edp-mitotane-adrenocortical-carcinoma-nejm-2012" ;
  schema:name "FIRM-ACT: combination chemotherapy in advanced adrenocortical carcinoma"@en ;
  schema:description "The first randomised trial in advanced adrenocortical carcinoma showed that etoposide, doxorubicin and cisplatin with mitotane shrank tumours more often and held them back longer than streptozocin with mitotane, making EDP-mitotane the standard."@en ;
  schema:url <https://onco.cc/key-papers/paper-firm-act-edp-mitotane-adrenocortical-carcinoma-nejm-2012/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1200966>, <https://pubmed.ncbi.nlm.nih.gov/22551107/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1200966> ;
  schema:datePublished "2012"^^xsd:gYear ;
  schema:author "Fassnacht M, Terzolo M, Allolio B, et al." ;
  onco:cancers <https://onco.cc/cancers/advanced-adrenocortical-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/mitotane/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:journals <https://onco.cc/journals/nejm/> .